Job Closed
This listing is no longer active.
Building on our impossible firsts, we can change the course of human health.
Associate Director – Health Economics and Outcomes Research, HEOR, Early Stage Pipeline
Location
United States
Posted
116 days ago
Salary
$180K - $250K / year
Seniority
Senior
Job Description
Associate Director – Health Economics and Outcomes Research, HEOR, Early Stage Pipeline
Ionis Pharmaceuticals, Inc.
• The Associate Director/ Director of Health Economics and Outcomes Research (Early Stage Pipeline) will be responsible for defining and executing early evidence generation strategies and deliverables across multiple programs. • Support HEOR/COA endpoint strategy from Phase 1 to 3 clinical studies ensuring inclusion of patient-centric, clinically meaningful, and economically relevant outcomes. • Contribute to commercial and global market access strategy to influence trial designs that meet expectations from multiple stakeholders. • Lead development of HTA-grade cost-effectiveness and budget-impact models to support early decision-making, identify value drivers, pricing, value dossiers, and individual country-specific submissions. • Contribute to global HEOR evidence-generation strategies by asset, aligning development programs with regulatory, HCP, and payer/HTA expectations. • Build relationships with clinical and HEOR/HTA thought leaders and academic collaborators shaping input to specific projects and methodologies, particularly in rare disease.
Job Requirements
- Advanced degree(s) (MD, PhD, PharmD, MSc, MPH, or equivalent) in Health Economics, Outcomes Research, Economics, Health Services Research, Business or psychometrics.
- Associate Director: 8+ years and a master’s degree; or a PhD with 5+ years’ experience in pharmaceutical, biotechnology, or HEOR consulting environments; rare disease or neurology/cardiometabolic experience preferred.
- Director: 12+ years and a master’s degree; or a PhD with 8+ years’ experience in pharmaceutical, biotechnology, or HEOR consulting environments; rare disease or neurology/cardiometabolic experience preferred.
- Excellent communicator with proven interpersonal skills and ability to influence R&D, Commercial, Medical, and Regulatory teams.
- Strong scientific writing and oral presentation skills.
- Travel expectation is 30%.
- Solid, firsthand experience with analysis of HTA-grade cost-effectiveness and budget-impact models; experience with evidence development for payer/HTA early scientific advice is a plus.
Benefits
- Highly competitive benefits
Related Guides
Related Categories
Related Job Pages
More Director Jobs
Director of Infrastructure
Shady Grove FertilityOver 100,000 babies born | Over 50 locations nationwide | #MiraclesMadeHere
• Oversee day-to-day management of a highly skilled team of network engineers and system administrators • Work with the internal and external stakeholders to help define priorities and manage work intake • Facilitate discussions across the disparate teams making sure communication is flowing in all directions • Provide technical escalation point for production issues • Perform capacity Management and budget planning to ensure infrastructure is in place to meet the needs of the business • Prioritize multiple work streams simultaneously and meet project deadlines • Capture metrics to help make decisions based on the data • Create detailed Documentation
• Build, manage, and develop a team of 15+ data scientists across Growth, Risk, Core Product and business expansion to help Mercury make better decisions informed by data. • Influence data analytics and data engineering culture and rigor across different levels, from executives to individual product and operations teams. • Guide the strategy, architecture, and tooling of Mercury’s data infrastructure to enable the entire company to use data effectively.
Associate Director/Director, Health Economics and Outcomes Research – Early Stage Pipeline
Ionis Pharmaceuticals, Inc.Building on our impossible firsts, we can change the course of human health.
• The Associate Director/ Director of Health Economics and Outcomes Research (Early Stage Pipeline) will be responsible for defining and executing early evidence generation strategies and deliverables across multiple programs. • Support HEOR/COA endpoint strategy from Phase 1 to 3 clinical studies ensuring inclusion of patient-centric, clinically meaningful, and economically relevant outcomes. • Contribute to commercial and global market access strategy to influence trial designs that meet expectations from multiple stakeholders. • Lead development of HTA-grade cost-effectiveness and budget-impact models to support early decision-making, identify value drivers, pricing, value dossiers, and individual country-specific submissions. • Partner with Global/US Market Access and Regulatory to ensure pivotal studies capture relevant endpoints.
Executive Director, US Value & Access
Ionis Pharmaceuticals, Inc.Building on our impossible firsts, we can change the course of human health.
• Own the development and execution of integrated U.S. payer strategies across the Ionis commercial portfolio. • Establish long-range access vision, coverage objectives, and reimbursement strategies aligned with brand and corporate priorities. • Shape and implement enterprise-level access frameworks that can scale across current and future launches. • Identify, quantify, and proactively mitigate access risks and reimbursement barriers. • Provide forward-looking analysis of payer landscape shifts, policy changes, and competitive access dynamics. • Lead U.S. access readiness strategy from pre-launch planning through lifecycle optimization. • Oversee development of payer-facing and field access materials. • Ensure alignment of clinical and economic evidence generation with payer requirements in partnership with HEOR and Medical Affairs. • Influence economic modeling, value frameworks, and budget impact strategies to support coverage negotiations. • Oversee pull-through strategies to accelerate coverage adoption and minimize patient access friction. • Lead and develop a high-performing U.S. Value & Access organization and drive team execution to achieve measurable access outcomes. • Establish clear strategic priorities and ensure alignment of resources against enterprise objectives. • Build scalable capabilities to support portfolio expansion and future product launches. • Foster a culture of collaboration, accountability, and continuous improvement. • Partner closely with Brand, Medical Affairs, HEOR, Regulatory, Government Affairs, Pricing, Field Access, and Sales leadership to ensure cohesive execution. • Integrate payer insights into brand planning, evidence strategies, and lifecycle investment decisions. • Provide executive-level recommendations to senior leadership on reimbursement strategy and payer engagement.


